GILD vs ISRG
Based on Invest's signal, Gilead Sciences Inc (GILD) currently has the stronger Buy/Hold/Sell rating of the two — a hold versus sell for ISRG.
| Metric | GILD | ISRG |
|---|---|---|
| Price | $129.31 | $337.50 |
| Day change | -1.2% | +1.7% |
| Market cap | $160.5B | $120.9B |
| P/E ratio | 17.6 | 41.0 |
| 1-year return | +13.9% | -32.8% |
| Invest signal | Hold | Sell |
Higher market cap, higher 1-year return, lower P/E, and a stronger signal are highlighted. Data is for learning, not financial advice.
Can't decide? Trade both — risk-free.
Start with €1,000,000 in virtual cash and practice buying GILD and ISRG at live prices.
GILD vs ISRG: FAQ
Is GILD or ISRG the better stock to buy?
Based on Invest's signal, Gilead Sciences Inc (GILD) currently has the stronger Buy/Hold/Sell rating of the two — a hold versus sell for ISRG. Remember that Invest's signal is a data-driven snapshot for learning, not financial advice — the best way to understand the difference is to add both to a watchlist and practice trading them with virtual cash.
Which is bigger, GILD or ISRG?
Gilead Sciences Inc is the larger company by market capitalisation ($160.5B vs $120.9B).
Can I practice trading GILD and ISRG for free?
Yes. Invest is a free stock market simulator — you start with €1,000,000 in virtual cash and can buy and sell both GILD and ISRG at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.